ArticleBMC pharmacology & toxicology2026
Omega-3 fatty acids attenuate alterations in penile erectile response by enhancing sexual behavior, nitric oxide-mediated signaling, and penile antioxidant status in tamoxifen-exposed rats.
Article in BMC pharmacology & toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe major type of breast cancer in males is the estrogen receptor-positive breast cancer, and can be managed with antiestrogenic hormonal compounds that have been reported to impair sexual functions in males. The commonest of these antiestrogenic agents is tamoxifen (TAM), which has also been shown to impair erectile function. Omega-3 fatty acids (O3FA), on the other hand, are an antioxidant obtained from diets, and they possess fertility-enhancing properties. In light of these, we considered the effect of O3FA on TAM-induced alterations in penile erectile response in male Wistar rats.
methodSixty (60) male Wistar rats were randomized into four oral treatment groups (15 animals/group): control, O3FA (300 mg/kg), TAM (0.4 mg/kg), and TAM+O3FA treatment group. Male rats were placed in transparent cages under dim light, paired with hormonally primed receptive females, and sexual behavior was assessed before biochemical analysis.
resultsTAM significantly disrupted male penile erectile reflexes and motivation to mate and decreased dopamine with the concomitant increase in serotonin, monoamine oxidase, arginase, and phosphodiesterase-5. These events were accompanied by a significant decrease in nitric oxide (NO) and cyclic guanosine monophosphate (cGMP). Also, TAM exposure altered antioxidant status (evidenced by a significant increase in penile MDA and decrease in Nrf2, SOD, CAT, GSH, and GPx), leading to penile inflammatory response (increased IL-1β, TnF-α, MPO, Nf-κb, XO, and UA) and caspase-3-mediated apoptosis. However, O3FA co-treatment attenuated TAM-induced alterations in penile erectile response and boosted the NO-mediated signaling and antioxidant status.
conclusionBased on these results, TAM administration in healthy rats was associated with increased penile oxidative stress, while O3FA attenuated some of these changes. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.